Skip to main navigation Skip to search Skip to main content

AVANT GUARD: A Prospective Randomized Multicenter Global Study Comparing Pulsed Field Ablation versus Anti-Arrhythmic Drug Therapy as a First Line Treatment for Persistent Atrial Fibrillation

Project: Research

Project Details

StatusActive
Effective start/end date04/22/2406/5/28

Funding

  • Boston Scientific Corporation: $36,359.10